delpacibart etedesiran   Click here for help

GtoPdb Ligand ID: 14730

Synonyms: AOC 1001 | AOC-1001 | del-desiran
Compound class: Nucleic acid
Comment: Delpacibart etedesiran (AOC 1001) is structurally a monoclonal antibody (mAb)-oligonucleotide conjugate (AOC) in which the mAb binds the transferrin receptor (TFRC;) for targeted delivery of a duplex small interfering RNA (siRNA) payload that degrades the mRNA that encodes DM1 protein kinase (DMPK) [1].

This entry provides information on the siRNA as the component that mediates the agent's intended pharmacodynamic effect. Further details about the parental anti-TFRC mAb are provided in the delpacibart entry. To improve pharmacokinetics and RNA binding the nucleotides in etedesiran are chemically modified (2'-O-methyl/2'-MOE monomers), with a mixed phosphorothioate/phosphate backbone. The mAb is attached to the siRNAs via malemide linkers at Cys-R positions on the passenger strands.

Delpacibart etedesiran is proposed to reduce the global splicing defects that arise from toxic gain-of-function DMPK transcript accummulation in myocytes in myotonic dystrophy type 1.
Nucleic Acid Sequence Click here for help
siRNA1:
(5'-3')UUGGGAUCUUGACAGAAGCUU
(3'-5')Cys-R-CCCUAGAACUGUCUUCGAA
siRNA2:
(5'-3')UUGGGAUCUUGACAGAAGCUU
(3'-5')Cys-R-CCCUAGAACUGUCUUCGAA